Hutson Nancy J Insider Trades

Insider Trading History

Track insider trading activity for Hutson Nancy J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $923k 99,138 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$283k 27,181 shares
$10.40
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $807k 86,638 shares
Last Trade
Dec 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$52.8k 7,000 shares
$7.54
$9.31
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $18.5k 45,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.8k 45,000 shares
$1.15
$0.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $872k 93,638 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$315k 49,933 shares
$6.30
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $808k 86,818 shares
Last Trade
May 20, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.9k 5,000 shares
$6.38
$9.31
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $38.1k 93,000 shares
Last Trade
Oct 03, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.6k 10,000 shares
$0.86
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $12.3k 30,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.3k 30,000 shares
$1.31
$0.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $762k 81,818 shares
Last Trade
Jun 14, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$103k 12,866 shares
$8.04
$9.31
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $882k 94,684 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$320k 39,072 shares
$8.18
$9.31
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $2.63k 37,510 shares
Last Trade
May 19, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263 3,750 shares
$0.07
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $0 0 shares
Last Trade
May 19, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263 3,750 shares
$0.07
$0.07
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $34k 83,000 shares
Last Trade
Nov 17, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$39.9k 30,000 shares
$1.33
$0.41
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $12.3k 30,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.6k 30,000 shares
$1.62
$0.41
Biocryst Pharmaceuticals
Biocryst Pharmaceuticals BCRX
Director
Holding Value $726k 77,939 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$787k 72,910 shares
$10.79
$9.31
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $1.23k 17,500 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.9k 21,250 shares
$0.84
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $0 0 shares
Last Trade
Nov 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.3k 7,400 shares
$3.15
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $2.37k 33,760 shares
Last Trade
Nov 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.3k 7,400 shares
$3.15
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $519 7,400 shares
Last Trade
Nov 05, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$100k 26,360 shares
$3.80
$0.07
PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals PHAS
Director
Holding Value $1.85k 26,360 shares
Last Trade
Nov 05, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$100k 26,360 shares
$3.80
$0.07
Clearside Biomedical
Clearside Biomedical CLSD
Director
Holding Value $21.7k 53,000 shares
Last Trade
Oct 29, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$218k 40,000 shares
$5.46
$0.41

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up